Xiaofeng Zhang

Xiaofeng Zhang

Auto-generated profile, based on publicly available information

Xiaofeng Zhang

University of Science and Technology of China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2017 in Cell
Verified
Journal Article
Closed access
XZXiaofeng Zhang
Xiaofeng Zhang
CYChuangye Yan
Chuangye Yan
JHJing Hang
Jing Hang
LFLorenzo I. Finci
Lorenzo I. Finci
JLJianlin Lei
Jianlin Lei
YSYigong Shi
Yigong Shi

23 January 2018 in Cell Research
Verified
Journal Article
Open access
PDF file
XZXiaofeng Zhang
Xiaofeng Zhang
CYChuangye Yan
Chuangye Yan
XZXiechao Zhan
Xiechao Zhan
LLLijia Li
Lijia Li
JLJianlin Lei
Jianlin Lei
YSYigong Shi
Yigong Shi
During each cycle of pre-mRNA splicing, the pre-catalytic spliceosome (B complex) is converted into the activated spliceosome (Bact complex), which has a well-formed active site but cannot proceed to the branching reaction. Here, we present the cryo-EM structure of the human Bact complex in three distinct conformational states. The EM map allows atomic modeling of nearly all protein components of the U2 small nuclear ribonucleoprotein (snRNP), including three of the SF3a complex and seven of the SF3b complex. The structure of the human Bact complex contains 52 proteins, U2, U5, and U6 small nuclear RNA (snRNA), and a pre-mRNA. Three distinct conformations have been captured, representing the early, mature, and late states of the human Bact complex. These complexes differ in the orientation of the Switch loop of Prp8, the splicing factors RNF113A and NY-CO-10, and most components of the NineTeen complex (NTC) and the NTC-related complex. Analysis of these three complexes and comparison with the B and C complexes reveal an ordered flux of components in the B-to-Bact and the Bact-to-B* transitions, which ultimately prime the active site for the branching reaction.

2 February 2018 in Science
Verified
Journal Article
Closed access
PDF file
XZXiechao Zhan
Xiechao Zhan
CYChuangye Yan
Chuangye Yan
XZXiaofeng Zhang
Xiaofeng Zhang
JLJianlin Lei
Jianlin Lei
YSYigong Shi
Yigong Shi
Structure of the human spliceosome: Catalyzed by the spliceosome, precursor mRNA splicing proceeds in two steps: branching and exon ligation. Transition from the C (catalytic post-branching spliceosome) to the C* (catalytic pre-exon ligation spliceosome) complex is driven by the adenosine triphosphatase/helicase Prp16. Zhan et al. report the cryo-electron microscopy structure of the human C complex, showing that two step I splicing factors stabilize the active site and link it to Prp16. Science , this issue p. 537

12 October 2018 in Cell Research
Verified
Journal Article
Open access
PDF file
XZXiechao Zhan
Xiechao Zhan
CYChuangye Yan
Chuangye Yan
XZXiaofeng Zhang
Xiaofeng Zhang
JLJianlin Lei
Jianlin Lei
YSYigong Shi
Yigong Shi
The pre-catalytic spliceosome (B complex) is preceded by its precursor spliceosome (pre-B complex) and followed by the activated spliceosome (Bact complex). The pre-B-to-B and B-to-Bact transitions are driven by the ATPase/helicases Prp28 and Brr2, respectively. In this study, we report the cryo-electron microscopy structures of the human pre-B complex and the human B complex at an average resolution of 5.7 and 3.8 Å, respectively. In the pre-B complex, U1 and U2 small nuclear ribonucleoproteins (snRNPs) associate with two edges of the tetrahedron-shaped U4/U6.U5 tri-snRNP. The pre-mRNA is yet to be recognized by U5 or U6 small nuclear RNA (snRNA), and loop I of U5 snRNA remains unengaged. In the B complex, U1 snRNP and Prp28 are dissociated, the 5’-exon is anchored to loop I of U5 snRNA, and the 5′-splice site is recognized by U6 snRNA through duplex formation. In sharp contrast to S. cerevisiae, most components of U2 snRNP and tri-snRNP, exemplified by Brr2, undergo pronounced rearrangements in the human pre-B-to-B transition. Structural analysis reveals mechanistic insights into the assembly and activation of the human spliceosome.

1 February 2018 in Genes & Development
Verified
Journal Article
Open access
PDF file
LFLorenzo I. Finci
Lorenzo I. Finci
XZXiaofeng Zhang
Xiaofeng Zhang
XHXiuliang Huang
Xiuliang Huang
QZQiang Zhou
Qiang Zhou
JTJennifer Tsai
Jennifer Tsai
NLNicholas A. Larsen
Nicholas A. Larsen
Somatic mutations in spliceosome proteins lead to dysregulated RNA splicing and are observed in a variety of cancers. These genetic aberrations may offer a potential intervention point for targeted therapeutics. SF3B1, part of the U2 small nuclear RNP (snRNP), is targeted by splicing modulators, including E7107, the first to enter clinical trials, and, more recently, H3B-8800. Modulating splicing represents a first-in-class opportunity in drug discovery, and elucidating the structural basis for the mode of action opens up new possibilities for structure-based drug design. Here, we present the cryogenic electron microscopy (cryo-EM) structure of the SF3b subcomplex (SF3B1, SF3B3, PHF5A, and SF3B5) bound to E7107 at 3.95 Å. This structure shows that E7107 binds in the branch point adenosine-binding pocket, forming close contacts with key residues that confer resistance upon mutation: SF3B1R1074H and PHF5AY36C. The structure suggests a model in which splicing modulators interfere with branch point adenosine recognition and supports a substrate competitive mechanism of action (MOA). Using several related chemical probes, we validate the pose of the compound and support their substrate competitive MOA by comparing their activity against both strong and weak pre-mRNA substrates. Finally, we present functional data and structure–activity relationship (SAR) on the PHF5AR38C mutation that sensitizes cells to some chemical probes but not others. Developing small molecule splicing modulators represents a promising therapeutic approach for a variety of diseases, and this work provides a significant step in enabling structure-based drug design for these elaborate natural products. Importantly, this work also demonstrates that the utilization of cryo-EM in drug discovery is coming of age.

6 February 2019 in Cell Research
Verified
Journal Article
Open access
PDF file
XZXiaofeng Zhang
Xiaofeng Zhang
XZXiechao Zhan
Xiechao Zhan
CYChuangye Yan
Chuangye Yan
WZWenyu Zhang
Wenyu Zhang
DLDongliang Liu
Dongliang Liu
YSYigong Shi
Yigong Shi
Pre-mRNA splicing is executed by the spliceosome, which has eight major functional states each with distinct composition. Five of these eight human spliceosomal complexes, all preceding exon ligation, have been structurally characterized. In this study, we report the cryo-electron microscopy structures of the human post-catalytic spliceosome (P complex) and intron lariat spliceosome (ILS) at average resolutions of 3.0 and 2.9 Å, respectively. In the P complex, the ligated exon remains anchored to loop I of U5 small nuclear RNA, and the 3′-splice site is recognized by the junction between the 5′-splice site and the branch point sequence. The ATPase/helicase Prp22, along with the ligated exon and eight other proteins, are dissociated in the P-to-ILS transition. Intriguingly, the ILS complex exists in two distinct conformations, one with the ATPase/helicase Prp43 and one without. Comparison of these three late-stage human spliceosomes reveals mechanistic insights into exon release and spliceosome disassembly.